Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy
Status:
Completed
Trial end date:
2019-02-28
Target enrollment:
Participant gender:
Summary
This randomized phase II/III trial studies gabapentin in reducing the need for pain
medication in patients with bladder cancer undergoing surgery to remove the bladder and
nearby tissue and organs. Gabapentin may reduce the amount of pain medicine required after
surgery, improve pain after surgery, and/or reduce the length of hospital stay after surgery.